Geron corporation – product pipeline review – 2012

287 views
271 views

Published on

2012 Aarkstore.com | Geron Corporation – Product Pipeline Review – 2012

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
287
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Geron corporation – product pipeline review – 2012

  1. 1. Aarkstore.com announces, The Latest market research report is available inits vast collection:Geron Corporation – Product Pipeline Review – 2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s pharmaceuticals report, “Geron Corporation - ProductPipeline Review - 2012” provides data on the Geron Corporation’s research anddevelopment focus. The report includes information on current developmentalpipeline, complete with latest updates, and features on discontinued and dormantprojects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, Geron Corporation’s corporate website, SEC filings, investorpresentations and featured press releases, both from Geron Corporation andindustry-specific third party sources, put together by Global Markets Direct’s team.Scope- Geron Corporation - Brief Geron Corporation overview including businessdescription, key information and facts, and its locations and subsidiaries.- Review of current pipeline of Geron Corporation human therapeutic division.- Overview of pipeline therapeutics across various therapy areas.Table of contents:List of Tables 5
  2. 2. List of Figures 6Geron Corporation Snapshot 7Geron Corporation Overview 7Key Information 7Key Facts 7Geron Corporation – Research and Development Overview 8Key Therapeutic Areas 8Geron Corporation – Pipeline Review 10Pipeline Products by Stage of Development 10Pipeline Products – Monotherapy 11Pipeline Products – Combination Treatment Modalities 12Geron Corporation – Pipeline Products Glance 13Geron Corporation Clinical Stage Pipeline Products 13Phase II Products/Combination Treatment Modalities 13Phase I Products/Combination Treatment Modalities 14Geron Corporation – Early Stage Pipeline Products 15Pre-Clinical Products/Combination Treatment Modalities 15Discovery Products/Combination Treatment Modalities 16Geron Corporation – Drug Profiles 17GRN1005 17Product Description 17Mechanism of Action 17R&D Progress 17GRN163L 19Product Description 19Mechanism of Action 19R&D Progress 19GRN163L + Paclitaxel + Bevacizumab 21Product Description 21Mechanism of Action 21R&D Progress 21GRN163L + Paclitaxel + Carboplatin 23Product Description 23Mechanism of Action 23R&D Progress 23
  3. 3. GRN510 25Product Description 25Mechanism of Action 25R&D Progress 25Hepatocytes 26Product Description 26Mechanism of Action 26R&D Progress 26List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012http://www.aarkstore.com/search/viewresults.asp?search=Product PipelineReview – 2012&PubId=&pagenum=1Genta Incorporated – Product Pipeline Review – 2012Geron Corporation – Product Pipeline Review – 2012Glenmark Pharmaceuticals Ltd. – Product Pipeline Review – 2012iBio, Inc. – Product Pipeline Review – 2012ImmunoGen, Inc. – Product Pipeline Review – 2012Can-Fite BioPharma Ltd. – Product Pipeline Review – 2012
  4. 4. Celtic Biotech, Ltd. – Product Pipeline Review – 2012Cyclacel Pharmaceuticals Inc. – Product Pipeline Review – 2012Endocyte, Inc. – Product Pipeline Review – 2012Flamel Technologies S.A. – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: enquiry@aarkstore.com

×